These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 29722820
1. Leishmania (Viannia) guyanensis in tegumentary leishmaniasis. Borges AF, Gomes RS, Ribeiro-Dias F. Pathog Dis; 2018 Jun 01; 76(4):. PubMed ID: 29722820 [Abstract] [Full Text] [Related]
2. Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil. Pires Ada S, Borges AF, Cappellazzo Coelho A, Dorta ML, Lino Junior Rde S, Pereira LI, Pinto SA, Pelli de Oliveira MA, de Matos GG, Abrahamsohn IA, Uliana SR, Lima GM, Ribeiro-Dias F. Biomed Res Int; 2015 Jun 01; 2015():350764. PubMed ID: 26583102 [Abstract] [Full Text] [Related]
3. Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients. Cantanhêde LM, da Silva Júnior CF, Ito MM, Felipin KP, Nicolete R, Salcedo JM, Porrozzi R, Cupolillo E, Ferreira Rde G. PLoS Negl Trop Dis; 2015 Jun 01; 9(9):e0004079. PubMed ID: 26372217 [Abstract] [Full Text] [Related]
4. Presence of Leishmania RNA Virus 1 in Leishmania guyanensis Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse. Bourreau E, Ginouves M, Prévot G, Hartley MA, Gangneux JP, Robert-Gangneux F, Dufour J, Sainte-Marie D, Bertolotti A, Pratlong F, Martin R, Schütz F, Couppié P, Fasel N, Ronet C. J Infect Dis; 2016 Jan 01; 213(1):105-11. PubMed ID: 26123564 [Abstract] [Full Text] [Related]
5. Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis. Rossi M, Castiglioni P, Hartley MA, Eren RO, Prével F, Desponds C, Utzschneider DT, Zehn D, Cusi MG, Kuhlmann FM, Beverley SM, Ronet C, Fasel N. Proc Natl Acad Sci U S A; 2017 May 09; 114(19):4987-4992. PubMed ID: 28439019 [Abstract] [Full Text] [Related]
6. Unveiling the Enigmatic nature of six neglected Amazonian Leishmania (Viannia) species using the hamster model: Virulence, Histopathology and prospection of LRV1. Soares RP, Fontes IC, Dutra-Rêgo F, Rugani JN, Moreira POL, da Matta VLR, Flores GVA, Pacheco CMS, de Andrade AJ, da Costa-Ribeiro MCV, Shaw JJ, Laurenti MD. PLoS Negl Trop Dis; 2024 Aug 09; 18(8):e0012333. PubMed ID: 39121159 [Abstract] [Full Text] [Related]
7. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, Schutz F, Zangger H, Revaz-Breton M, Lye LF, Hickerson SM, Beverley SM, Acha-Orbea H, Launois P, Fasel N, Masina S. Science; 2011 Feb 11; 331(6018):775-8. PubMed ID: 21311023 [Abstract] [Full Text] [Related]
8. Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis. Olivier M, Zamboni DS. Curr Opin Immunol; 2020 Oct 11; 66():108-113. PubMed ID: 32877837 [Abstract] [Full Text] [Related]
9. Leishmaniavirus genetic diversity is not related to leishmaniasis treatment failure. Ginouvès M, Couppié P, Simon S, Bourreau E, Rogier S, Brousse P, Travers P, Pommier de Santi V, Demar M, Briolant S, Prévot G. Clin Microbiol Infect; 2021 Feb 11; 27(2):286.e1-286.e5. PubMed ID: 32380286 [Abstract] [Full Text] [Related]
10. Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid. Castiglioni P, Hartley MA, Rossi M, Prevel F, Desponds C, Utzschneider DT, Eren RO, Zangger H, Brunner L, Collin N, Zehn D, Kuhlmann FM, Beverley SM, Fasel N, Ronet C. PLoS Negl Trop Dis; 2017 Jan 11; 11(1):e0005240. PubMed ID: 28099431 [Abstract] [Full Text] [Related]
11. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil. Romero GA, de la Glória Orge Orge M, de Farias Guerra MV, Paes MG, de Oliveira Macêdo V, de Carvalho EM. Acta Trop; 2005 Jan 11; 93(1):49-56. PubMed ID: 15589797 [Abstract] [Full Text] [Related]
12. Leishmania guyanensis M4147 as a new LRV1-bearing model parasite: Phosphatidate phosphatase 2-like protein controls cell cycle progression and intracellular lipid content. Zakharova A, Albanaz ATS, Opperdoes FR, Škodová-Sveráková I, Zagirova D, Saura A, Chmelová L, Gerasimov ES, Leštinová T, Bečvář T, Sádlová J, Volf P, Lukeš J, Horváth A, Butenko A, Yurchenko V. PLoS Negl Trop Dis; 2022 Jun 11; 16(6):e0010510. PubMed ID: 35749562 [Abstract] [Full Text] [Related]
13. Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence. Eren RO, Reverte M, Rossi M, Hartley MA, Castiglioni P, Prevel F, Martin R, Desponds C, Lye LF, Drexler SK, Reith W, Beverley SM, Ronet C, Fasel N. Cell Host Microbe; 2016 Sep 14; 20(3):318-328. PubMed ID: 27593513 [Abstract] [Full Text] [Related]
14. Leishmania--a parasitized parasite. Scott P. N Engl J Med; 2011 May 05; 364(18):1773-4. PubMed ID: 21542750 [No Abstract] [Full Text] [Related]
15. Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response. Brettmann EA, Shaik JS, Zangger H, Lye LF, Kuhlmann FM, Akopyants NS, Oschwald DM, Owens KL, Hickerson SM, Ronet C, Fasel N, Beverley SM. Proc Natl Acad Sci U S A; 2016 Oct 25; 113(43):11998-12005. PubMed ID: 27790981 [Abstract] [Full Text] [Related]
16. Identification of antigenically distinct populations of Leishmania (Viannia) guyanensis from Manaus, Brazil, using monoclonal antibodies. Romero GA, Ishikawa E, Cupolillo E, Toaldo CB, Guerra MV, Paes MG, Macêdo Vde O, Shaw JJ. Acta Trop; 2002 Apr 25; 82(1):25-9. PubMed ID: 11904100 [Abstract] [Full Text] [Related]
17. Infection-induced respiratory burst in BALB/c macrophages kills Leishmania guyanensis amastigotes through apoptosis: possible involvement in resistance to cutaneous leishmaniasis. Sousa-Franco J, Araújo-Mendes E, Silva-Jardim I, L-Santos J, Faria DR, Dutra WO, Horta MF. Microbes Infect; 2006 Feb 25; 8(2):390-400. PubMed ID: 16242371 [Abstract] [Full Text] [Related]
18. Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama. Gonzalez K, De León SS, Pineda V, Samudio F, Capitan-Barrios Z, Suarez JA, Weeden A, Ortiz B, Rios M, Moreno B, Gundacker ND, Pascale JM, López-Vergès S, Sosa N, Saldaña A, Ábrego LE. Emerg Infect Dis; 2023 Jun 25; 29(6):1250-1253. PubMed ID: 37209675 [Abstract] [Full Text] [Related]
19. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verástegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A. J Infect Dis; 2007 Jun 15; 195(12):1846-51. PubMed ID: 17492601 [Abstract] [Full Text] [Related]
20. Influence of Leishmania RNA Virus 1 on Proinflammatory Biomarker Expression in a Human Macrophage Model of American Tegumentary Leishmaniasis. Kariyawasam R, Grewal J, Lau R, Purssell A, Valencia BM, Llanos-Cuentas A, Boggild AK. J Infect Dis; 2017 Oct 17; 216(7):877-886. PubMed ID: 28968786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]